Security key
25253X207
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)
CUSIP: 25253X207
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Voting Common Shares, no par value
- Total 13F shares
- 2,565,385
- Total 13F value
- $3,924,875
- Share change
- +41,212
- Put/Call ratio
- 9.1%
- SEC-reported price per share
- $1.53
- Number of holders
- 22
- Value change
- +$61,558
- Number of buys
- 8
- Number of sells
- 8
- Shares outstanding
- 52,272,727
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
22
Top holders
10
DMAC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
DiaMedica Therapeutics Inc. SEC filings
DiaMedica Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 25253X207
Recent filing periods:
Ownership snapshot
Top reported holders of DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Leon G. Cooperman
Disclosed value leader
Leon G. Cooperman
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
Lead comparable stake: 1.6%
Showing 1-6 of 15 holder rows.
Quick read
Leon G. Cooperman leads the comparable SEC ownership view at 1.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Leon G. Cooperman's linked filing trail.
Comparable ownership
Top 5
Leon G. Cooperman
1.6%
VANGUARD GROUP INC
1.5%
JACOB ASSET MANAGEMENT OF NEW YOR...
0.45%
GEODE CAPITAL MANAGEMENT, LLC
0.35%
NORTHERN TRUST CORP
0.18%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Leon G. Cooperman |
13F
Individual
|
1.6%
|
$1,283,844
812,508 shares
|
— | 31 Dec 2022 |
| VANGUARD GROUP INC |
13F
Company
|
1.5%
|
$1,237,201
782,989 shares
|
— | 31 Dec 2022 |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC |
13F
Company
|
0.45%
|
$369,293
233,730 shares
|
— | 31 Dec 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.35%
|
$292,000
184,870 shares
|
— | 31 Dec 2022 |
| NORTHERN TRUST CORP |
13F
Company
|
0.18%
|
$147,057
93,068 shares
|
— | 31 Dec 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
0.13%
|
$110,508
69,937 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
22
Shares
2,565,385
Rows available
22
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
22
Q1 2023 holders
22
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend